Topiramate reduces levodopa‐induced dyskinesia in the MPTP‐lesioned marmoset model of Parkinson's disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Topiramate reduces levodopa‐induced dyskinesia in the MPTP‐lesioned marmoset model of Parkinson's disease

Published:2004-12-09 Issue:4 Volume:20 Page:403-409
ISSN:0885-3185
Container-title:Movement Disorders
language:en
Short-container-title:Mov. Disord.

Author:

Silverdale Monty A.¹²,Nicholson S.L.²,Crossman A.R.²³,Brotchie J.M.⁴

Affiliation:

1. Department of Neurology, Hope Hospital, Salford, Manchester, United Kingdom

2. Manchester Movement Disorder Laboratory, School of Biological Science, University of Manchester, Manchester, United Kingdom

3. Motac Neuroscience Ltd., Williams House, Manchester Science Park, Manchester, United Kingdom

4. Toronto Western Research Institute, Toronto Western Hospital, Toronto, Ontario, Canada

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/mds.20345

Reference36 articles.

1. Frequency of levodopa‐related dyskinesias and motor fluctuations as estimated from the cumulative literature

2. Aromatic Amino Acids and Modification of Parkinsonism

3. The phenomenology of L‐dopa‐induced dyskinesias in Parkinson's disease;Vidailhet M;Mov Disord,1999

4. AMPA receptor blockade improves levodopa-induced dyskinesia in MPTP monkeys

5. LY293558, an AMPA glutamate receptor antagonist, prevents and reverses levodopa-induced motor alterations in Parkinsonian rats

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Non-Negative Matrix Tri-Factorization for Representation Learning in Multi-Omics Datasets with Applications to Drug Repurposing and Selection;International Journal of Molecular Sciences;2024-09-04

2. Using artificial intelligence to identify drugs for repurposing to treat l-DOPA-induced dyskinesia;Neuropharmacology;2024-05

3. Glutamate Receptors and C-ABL Inhibitors: A New Therapeutic Approach for Parkinson's Disease;Central Nervous System Agents in Medicinal Chemistry;2024-04

4. Drug reprofiling history and potential therapies against Parkinson’s disease;Frontiers in Pharmacology;2022-10-26

5. Non-dopaminergic approaches to the treatment of motor complications in Parkinson's disease;Neuropharmacology;2022-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3